KIDS
Orthopediatrics Corp Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$30.87Close
$774.6MMarket cap
$14.64 – $31.5252-week range
Jan 22, 2027Next report · estimated
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 96 · stronger than 96% of stocks over 12 months
- Near its high 2% below its 52-week high
Cautions
- Past its pivot 33.6% above its $23.10 pivot
- Extended 7.2 ATR above its 50-day average
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
2%
1wk
up 26.0%
price change
1mo
up 38.6%
price change
12-month return
up 87%
market up 11% ·
its own up 77%
F-score
4 / 9
Weak
Altman Z
2.82
Moderate risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
2.2×
price / book
Earnings yield
down 4.6%
EBIT / enterprise value
Cheaper than
33%
of the market · expensive
Revenue growth
up 15%
year on year
EPS growth
—
latest quarter
Sales growth
up 19%
latest quarter · +3 pts
ROE
down 11%
return on equity
Free cash margin
down 7%
-$16.0M FCF
D/E
0.29
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
- not yet profitable on its assets
- operating cash flow is negative
- took on more long-term debt
- short-term liquidity weakened
- issued more shares
- profitability improving
- profits backed by cash
- gross margin widened
- assets working harder
Trade setup
ATR%
4.5%
$1.39 a day · 2×ATR $28.10
RS
96 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
2.1×
vs 50-day average
Up/down volume
1.10
50 sessions
Implied move
—
no scheduled report
Contractions
3
21% → 9% → 8%
Pivot
$23.10
33.6% above
Volume dry-up
2.0×
10 vs 50 sessions
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 3.6% over the year, from 24m to 25m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Oct 27, 2026
Results reaction
Oct 27, 2026+27% vs market2 sessions after results
Financials
- Gross 73%
- Net -17%
- Free cash -7%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $71.1M | $98.0M | $122.3M | $148.7M | $204.7M | $236.3M |
| Gross margin | 77% | 75% | 74% | 75% | 73% | 73% |
| Operating income | -$26.8M | -$18.0M | -$25.4M | -$26.8M | -$35.0M | -$39.2M |
| Net income | -$32.9M | -$16.3M | $1.3M | -$21.0M | -$37.8M | -$39.6M |
| Net margin | -46% | -17% | 1% | -14% | -18% | -17% |
| Earnings per share | -$1.82 | -$0.84 | $0.06 | -$0.92 | -$1.64 | -$1.69 |
| Free cash flow | -$29.0M | -$21.2M | -$31.8M | -$43.9M | -$41.3M | -$16.0M |
| Free cash margin | -41% | -22% | -26% | -30% | -20% | -7% |
| Cash | $28.8M | $7.6M | $9.0M | $31.1M | $43.8M | $19.6M |
| Long-term debt | $1.0M | $907,000 | $763,000 | $9.9M | $73.0M | $99.8M |
| Shareholders' equity | $234.8M | $225.4M | $378.6M | $377.0M | $354.6M | $346.6M |
| Shares outstanding | 19.56m | 19.68m | 22.88m | 23.38m | 24.22m | 25.09m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 28, 2026 | Quarterly ↗ | Sep 30, 2026 | 28d |
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 1, 2026 | Quarterly ↗ | Mar 31, 2026 | 31d |
| Mar 4, 2026 | Annual ↗ | Dec 31, 2025 | 63d |
| Oct 29, 2025 | Quarterly ↗ | Sep 30, 2025 | 29d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Mar 5, 2025 | Annual ↗ | Dec 31, 2024 | 64d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Mar 8, 2024 | Annual ↗ | Dec 31, 2023 | 68d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Regulation FD ↗ |
| Oct 27, 2026 | Results ↗ |
| Aug 4, 2026 | Regulation FD ↗ |
| Aug 4, 2026 | Results ↗ |
| Jun 4, 2026 | Shareholder vote ↗ |
| Apr 30, 2026 | Regulation FD ↗ |
| Apr 30, 2026 | Results ↗ |
| Apr 1, 2026 | Material agreement · New obligation ↗ |
| Feb 26, 2026 | Regulation FD ↗ |
| Feb 26, 2026 | Results ↗ |
| Jan 12, 2026 | Regulation FD ↗ |
| Jan 12, 2026 | Results ↗ |